Chapter 4
The glass-and-steel headquarters of Calder Biotech towered over downtown Seattle, a monument to human ingenuity and corporate ambition. Inside the thirty-second-floor executive boardroom, the atmosphere was clinical, quiet, and intensely focused.
Dr. Aris Thorne, the senior director of research and development, leaned back in his leather chair, tapping a stylus against a digital tablet. Across the polished concrete conference table sat Clara, dressed in a sharp charcoal blazer over a silk blouse, her short brown hair neatly styled.
“Your credentials are undeniable, Ms. Vance,” Dr. Thorne said, his voice measured and professional. “Your undergraduate thesis on synthetic enzyme catalysis is already being cited by our senior labs. But we have a serious compliance issue on our hands.”
“I am fully aware of the situation with my father, Dr. Thorne,” Clara said without hesitation. She did not look down or fidget. “My personal life has no bearing on my scientific output, but I understand the board’s sensitivity regarding corporate partnerships and executive optics.”
“It’s not just optics,” Thorne corrected gently. “Your father sits on the advisory board of our primary capital venture partner, Vance Holdings. If there is an ongoing legal dispute between you and him involving misappropriated funds, it creates a conflict of interest that could jeopardize our upcoming series-C funding round.”
Clara slid a slim legal document across the table. “By nine o’clock this morning, my legal representation filed a formal petition for receivership against Vance Holdings, severing all financial and familial ties between myself and Julian Vance. Furthermore, I have placed my personal intellectual property rights into an independent trust managed by my uncle, completely outside my father’s reach.”
Thorne picked up the document, his eyes scanning the legal language with professional appreciation. A slow, approving smile broke through his stern expression. “You preempted the board’s concerns before we even had our morning briefing.”
“I don’t leave variables uncalculated,” Clara replied calmly.
“Clearly,” Thorne muttered, signing his initials at the bottom of the intake form and sliding it back. “Welcome to Calder Biotech, Clara. Your lab space is on the fourteenth floor. You start immediately.”
As Clara walked out of the boardroom and down the sprawling, sunlit corridor toward her new laboratory, she felt a profound weight lift from her shoulders. For the first time in her life, the name Vance did not feel like a shackle; it felt like a ghost she was finally putting to rest.
May you like
Back at the Vance estate, however, the ghost was very much alive and screaming. Julian paced his mahogany-paneled study, slamming the receiver of his secure desk phone down onto its cradle for the fourth time. The line was dead. Every financial institution he called had frozen his accounts pending the federal receivership review. His entire empire, built on smoke, mirrors, and borrowed capital, was dissolving before his eyes.
***
